# VitaDAO

> VitaDAO is a decentralized autonomous organization (DAO) dedicated to funding and advancing early-stage longevity science research. Members collectively govern a treasury and vote on research proposals using the VITA governance token on Ethereum.

## What is VitaDAO?

VitaDAO was founded in 2021 as a decentralized science (DeSci) pioneer. It funds and incubates longevity research, with the community governing research proposals and a shared treasury. Some projects use Intellectual Property Tokens (IPTs) to coordinate funding and governance around project IP. The VITA token (ERC-20) is VitaDAO's governance token.

## Key Pages

- [Home](https://www.vitadao.com): Mission and overview
- [Research](https://www.vitadao.com/research): How VitaDAO funds research via IPTs, Scientific Advisory Board, funded projects
- [Projects](https://www.vitadao.com/projects): All funded longevity research projects with status and updates
- [Blog](https://www.vitadao.com/blog): Research updates, longevity newsletters, and science articles
- [VITA Token](https://www.vitadao.com/vita-token): Governance token — how to acquire and use VITA
- [Why Longevity](https://www.vitadao.com/why-longevity): The scientific and moral case for longevity research
- [Vita App](https://www.vitadao.com/vita-app): Product landing page for VitaDAO's private health intelligence app
- [Launch Vita App](https://app.vitadao.com/login): External application for bringing labs, wearables, research-informed AI, and a Health Calendar into one private health record

## Research Areas

VitaDAO funds research across: senolytics, epigenetic reprogramming, gene therapy (VitaRNA/ARTAN Bio), metabolic aging (VITA-FAST), mTOR/rapamycin, stem cell biology, and computational aging models.

## Scientific Advisory Board

VitaDAO's Scientific Advisory Board (SAB) reviews research proposals before community voting:

- **Aubrey de Grey** — Biomedical gerontologist, founder of LEV Foundation, pioneer of the SENS (Strategies for Engineered Negligible Senescence) rejuvenation research framework
- **Matt Kaeberlein** — CEO of Optispan, Co-Founder of the Dog Aging Project, expert on rapamycin, mTOR, and biological mechanisms of aging; Professor at University of Washington
- **Marco Quarta** — CSO of Rubedo Life Sciences, former Stanford researcher in regenerative medicine and stem cell biology, expert in senolytics
- **Sebastian Brunemeier** — Partner at Long Game Ventures, biotech VC and founder of multiple longevity companies including Cambrian Biopharma and Samsara Therapeutics
- **Jack Scannell** — CEO of Etheros Pharmaceuticals, coined "Eroom's Law" describing the decline in pharma R&D productivity

## Governance

Proposals are reviewed by the Scientific Advisory Board and voted on by VITA token holders. Approved research receives funding and an IPT is minted representing the resulting intellectual property.

## Key Facts

- Founded: 2021
- Token: VITA (ERC-20 on Ethereum)
- Category: DeSci (Decentralized Science), Longevity, BioDAO
- Projects funded: 31
- Funding deployed: $4.7M
- Project FDV: $60.0M
- IPTs generated: 8
- Companies founded: 3
- Mechanism: Intellectual Property Tokens (IPTs)

## Common Questions

**What is an IPT?** An Intellectual Property Token (IPT) is a project-specific token associated with early-stage biotech intellectual property. VitaDAO projects may use IPTs to coordinate research funding and governance around project IP.

**What is the VITA token?** VITA is an ERC-20 governance token on Ethereum. Holders use it to vote on research funding proposals and treasury decisions.

**What is DeSci?** Decentralized Science — an emerging movement using blockchain technology to fund, govern, and commercialize scientific research without traditional institutional gatekeepers.

## Links

- Sitemap: https://www.vitadao.com/sitemap.xml
- Agent API: https://www.vitadao.com/.well-known/openapi.json
- Agent card (A2A): https://www.vitadao.com/.well-known/agent-card.json
- Agent manifest: https://www.vitadao.com/.well-known/agents.json